Physician profile
Pooja Kumar
NPI 1326253147
$2,831.35
in general payments reported to CMS, 2019-2025
14 companies · $15.58 in 2025
The $15.58 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $11.83 · 2021: $975 · 2022: $88.73 · 2023: $249 · 2024: $1,113 · 2025: $15.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,080 · Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,080.00 |
| Food and Beverage | $297.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $1,225.00 | 2021-2024 | |
| Acteon INC | $1,104.00 | 2019-2021 | |
| Keystone Dental INC. | $71.70 | 2022 | |
| Patterson Companies, INC. | $67.84 | 2023-2024 | |
| Kerr Corporation | $63.61 | 2019-2023 | Vertise Flow, Harmonize |
| Elevate Oral Care | $58.48 | 2022-2023 | Fluorimax Mint, Advantage Arrest, Just Right 5000 |
| Biolase, INC. | $56.00 | 2023 | Waterlase Iplus |
| Align Technology, INC. | $53.60 | 2019-2025 | Invisalign |
| Envista Holdings Corporation | $35.68 | 2024 | Maxcem Elite |
| Nobel Biocare USA | $33.35 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $25.71 | 2019-2020 | |
| Colgate Oral Pharmaceuticals, INC. | $13.88 | 2023 | |
| 3m Company | $13.58 | 2019 | |
| Voco America INC. | $8.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.